Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome

Int J Clin Exp Pathol. 2014 Sep 15;7(10):7110-3. eCollection 2014.

Abstract

Epstein-Barr virus (EBV) associated lymphoproliferative disease (LPD) are commonly derived from B-cells, however, it is becoming more and more apparently that EBV can also infect T-lymphocytes. Systemic EBV positive T-cell LPD of childhood is rare and characterized by an extremely aggressive course and poor prognosis. Here, we report a 22-year-old female of systemic EBV positive TLPD with acute EBV infection and review the clinical features of this disorder. A 22-year-old previously healthy female without immunocompromised status presented with persisting coach and fever resistant to conventional therapies. Physical examination showed hemorrhage and hepatosplenomegaly. Laboratory examinations revealed severe pancytopenia, disseminated intra-vascular coagulopathy (DIC), and anti-EBV-IgM positivity. Peripheral blood smears and bone marrow investigation identified a number of atypical lymphocytes. Flow cytometry (FCM) did not show any significant evidence of leukemia or lymphoma. The lymph node biopsy showed apparent infiltration of lymphocytes, which expressed CD2+, CD3+, CD7+ and TIA1+. There was no CD20+ or CD56+ cells. EBV early RNA (EBER) was positive. Cytogenetic analysis showed a normal karyotype. T-cell receptor (TCR) gene rearrangement revealed a polyclonal pattern. The patient received prednisolone and IVIG therapy with a transient good condition, and then died of multiorgan failure one week after diagnosis.

Keywords: Epstein-Barr virus; hemophagocytic syndrome; lymphoproliferative disease.

Publication types

  • Case Reports

MeSH terms

  • Biopsy
  • Epstein-Barr Virus Infections / diagnosis
  • Epstein-Barr Virus Infections / genetics
  • Epstein-Barr Virus Infections / immunology
  • Epstein-Barr Virus Infections / therapy
  • Epstein-Barr Virus Infections / virology*
  • Fatal Outcome
  • Female
  • Glucocorticoids / therapeutic use
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / isolation & purification*
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunohistochemistry
  • In Situ Hybridization
  • Lymph Nodes / immunology
  • Lymph Nodes / virology*
  • Lymphohistiocytosis, Hemophagocytic / diagnosis
  • Lymphohistiocytosis, Hemophagocytic / genetics
  • Lymphohistiocytosis, Hemophagocytic / immunology
  • Lymphohistiocytosis, Hemophagocytic / therapy
  • Lymphohistiocytosis, Hemophagocytic / virology*
  • Lymphoproliferative Disorders / diagnosis
  • Lymphoproliferative Disorders / genetics
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / therapy
  • Lymphoproliferative Disorders / virology*
  • Multiple Organ Failure / etiology
  • Phenotype
  • Prednisolone / therapeutic use
  • RNA, Viral / isolation & purification
  • T-Lymphocytes / immunology
  • T-Lymphocytes / virology*
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Glucocorticoids
  • Immunoglobulins, Intravenous
  • RNA, Viral
  • Prednisolone